2012
DOI: 10.3945/ajcn.111.022590
|View full text |Cite
|
Sign up to set email alerts
|

Effect of reducing the n−6:n−3 long-chain PUFA ratio during pregnancy and lactation on infant adipose tissue growth within the first year of life: an open-label randomized controlled trial

Abstract: We showed no evidence that supplementation with n-3 fatty acids and instructions to reduce arachidonic acid intake during pregnancy and lactation relevantly affects fat mass in offspring during the first year of life. Prospective long-term studies are needed to explore the efficacy of this dietary approach for primary prevention. This trial was registered at clinicaltrials.gov as NCT00362089.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
148
4
3

Year Published

2013
2013
2019
2019

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 110 publications
(162 citation statements)
references
References 44 publications
7
148
4
3
Order By: Relevance
“…We could not verify the initial hypothesis because we found no intervention effect on fat mass development in the offspring (15).…”
contrasting
confidence: 47%
See 1 more Smart Citation
“…We could not verify the initial hypothesis because we found no intervention effect on fat mass development in the offspring (15).…”
contrasting
confidence: 47%
“…This finding is consistent with previous reports from RCTs (16,(18)(19)(20), describing that n-3 LCPUFA supplementation during pregnancy and lactation does not decrease the proportion of AA in mature breast milk. Also, the concomitant moderate reduction in dietary AA intake during pregnancy in the present study (15) did not affect breast milk AA content. Indeed, breast milk AA is relatively uniform across populations on a worldwide basis (~0.24-1.0% of FAs) (21), suggesting a physiological and critical role of AA for infant growth and development.…”
Section: Discussionmentioning
confidence: 64%
“…The study rationale and design, baseline characteristics of the pregnant women as well as the clinical results on infant body composition up to 1 year of age were previously described in detail (15,16). In brief, 208 healthy pregnant women with a prepregnancy BMI between 18 and 30 kg m 22 were randomly assigned to either an intervention or a control group from the 15th week of gestation until 4 months postpartum (pp).…”
Section: Methodsmentioning
confidence: 99%
“…Anthropometric measurements in the infants were taken at birth (3-5 days pp for skinfolds), 6 weeks, 4 months, 1 year, and 2 years pp by trained investigators according to standardized procedures (15). Birth weight and length, head circumference and sex of the newborn were collected from the maternal obstetric record.…”
Section: Maternal Characteristics and Infant Anthropometrymentioning
confidence: 99%
“…Les reserves que l'on peut emettre sur ces etudes portent notamment sur le niveau de base moyen de consommation en AGPI qui semble adequat (et donc non desequilibre) dans la population supplementee (Hauner et al, 2012 long terme d'une supplementation en DHA, mais egalement sur un besoin specifique en DHA apres les 6 premiers mois de la vie.…”
Section: Abstract: Lipids In Infant Nutritionunclassified